IP Library Granted Patent US 8,765,955
Granted Patent B2
US 8,765,955 · App. 11/442,667 · Granted Jul 1, 2014

Asymmetric aldol additions using bifunctional cinchona-alkaloid-based catalysts

Inventors: Li Deng (Newton, MA); Hongming Li (Waltham, MA)
Assignee: Brandeis University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,955
App. No.
11/442,667
Granted
Jul 1, 2014
Kind
B2
Abstract

One aspect of the present invention relates to asymmetric catalytic nitroaldol (Henry) reactions with ketones as the electrophilic component. In one embodiment, the present invention relates to asymmetric nitroaldol reactions with α-keto esters catalyzed by a new C6′-OH cinchona alkaloid catalyst. In certain embodiments, this reaction is operationally simple and affords high enantioselectivity as well as good to excellent yield for an exceptionally broad range of α-keto esters.

Claims (30)

1. A compound represented by formula I:

wherein, independently for each occurrence:

R represents mono-substituted or unsubstituted phenyl, aryl, or heteroaryl;

R 1 represents ethyl or —CH═CH 2 ;

R 2 and R 3 represent lower alkyl, lower alkenyl, aryl, halogen, hydroxy, cyano, amino, alkoxyl, nitro, thiol, amido, carboxyl, alkylthio, or sulfonyl;

n is 0;

m is 0; and

R 4 represents —OH.

2. A compound represented by formula II:

wherein, independently for each occurrence:

R represents mono-substituted or unsubstituted phenyl, aryl, or heteroaryl;

R 1 represents ethyl or —CH═CH 2 ;

R 2 and R 3 represent lower alkyl, lower alkenyl, aryl, halogen, hydroxy, cyano, amino, alkoxyl, nitro, thiol, amido, carboxyl, alkylthio, or sulfonyl;

n is 0;

m is 0; and

R 4 represents —OH.

3. The compound of claim 1 or 2 , wherein R represents aryl or heteroaryl.

4. The compound of claim 1 or 2 , wherein R represents aryl.

5. The compound of claim 1 or 2 , wherein R represents mono-substituted or unsubstituted phenyl.

6. The compound of claim 1 or 2 , wherein R represents mono-substituted phenyl.

7. The compound of claim 1 or 2 , wherein R represents unsubstituted phenyl.

8. The compound of claim 1 or 2 , wherein R 1 is ethyl.

9. The compound of claim 1 or 2 , wherein R 1 is —CH═CH 2 .

10. The compound of claim 1 or 2 , wherein R is aryl and R 1 is ethyl.

11. The compound of claim 1 or 2 , wherein R is mono-substituted or unsubstituted phenyl and R 1 is ethyl.

12. The compound of claim 1 or 2 , wherein R is unsubstituted phenyl; and R 1 is ethyl.

13. The compound of claim 1 or 2 , wherein R is aryl and R 1 is —CH═CH 2 .

14. The compound of claim 1 or 2 , wherein R is mono-substituted or unsubstituted phenyl and R 1 is —CH═CH 2 .

15. The compound of claim 1 or 2 , wherein R is unsubstituted phenyl; and R 1 is —CH═CH 2 .

16. A compound, selected from the group consisting of:

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 4, 2011
From: BRANDEIS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026698/0830 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2007
From: DENG, LI; LI, HONGMING
To: BRANDEIS UNIVERSITY
Reel/Frame 018789/0389 →
Continuity (6)
Continuation In Part 11140574 · May 27, 2005
Provisional Application 60576754 · Jun 3, 2004
Provisional Application 60592500 · Jul 30, 2004
Provisional Application 60741639 · Dec 1, 2005
Provisional Application 60742102 · Dec 2, 2005
Related Publication 20070112199A1 · May 17, 2007